Companies / SpyGlass Pharma, Inc. / Activity
Activity — SpyGlass Pharma, Inc.
10 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | RA Capital Management, L.P. 13F manager | New | Common Stock | $207.83M | +8.0M | 8,021,117 23.98% of shares | high |
| Q2 2026 as of | BlackRock, Inc. 13F manager | New | Common Stock | $15.84M | +712K | 711,712 2.13% of shares | medium |
| Q1 2026 as of | Deerfield Management Company, L.P. 13F manager | New | Common Stock | $14.25M | +550K | 550,000 1.64% of shares | medium |
| Q1 2026 as of | Millennium Management LLC 13F manager | New | Common Stock | $12.15M | +469K | 468,794 1.40% of shares | medium |
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | New | Common Stock | $3.28M | +127K | 126,540 0.38% of shares | low |
| Q2 2026 as of | State Street Corporation 13F manager | New | Common Stock | $2.62M | +118K | 117,561 0.35% of shares | low |
| Q1 2026 as of | TD Asset Management Inc 13F manager | New | Common Stock | $1.23M | +48K | 47,580 0.14% of shares | low |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | New | Common Stock | $760.4K | +29K | 29,348 0.09% of shares | low |
| Q2 2026 as of | Deutsche Bank AG 13F manager | New | Common Stock | $244.0K | +11K | 10,962 0.03% of shares | low |
| Q1 2026 as of | Royal Bank of Canada 13F manager | New | Common Stock | $2.0K | +85 | 85 <0.01% of shares | low |